Comments
Laurus Labs Ltd has received a final approval from United States Food and Drug Administration (US FDA) for Hydroxychloroquine Tablets.
The approved drug is used for treatment of certain type of Malaria. This medication is also used, usually with other medications, to treat certain auto-immune diseases (lupus, rheumatoid arthritis) when other medications have not worked or cannot be used.
The tablet is therapeutically equivalent to Plaquenil tablets of Concordia Pharmaceuticals, Inc.
In another development, the company also received a tentative approval for an ANDA for Abacavir, Dolutegravir, and Lamivudine tablets from USFDA.
The products will be commercialized from Laurus’ manufacturing site located at Atchutapuram, Visakhapatnam.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.